Home and specialty infusion is a vast arena of pharmaceutical services provided in the outpatient setting, typically in the patient’s home or an infusion suite. The majority of these medications involve administration through a needle or catheter, otherwise known as infusion, while others are administered via alternate routes of administration such as intramuscular, epidural, and self-injectable means. Infusion medications are prescribed for both acute and chronic illnesses that cannot be effectively treated with oral medications alone. Patients may shorten or avoid stays in institutions such as hospitals and nursing homes when their infusion therapy can be provided in alternate-site settings including their homes and ambulatory infusion centers.

Market Analysis and Insights: Global Home and Alternate Site Infusion Therapy Market
The global Home and Alternate Site Infusion Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Home and Alternate Site Infusion Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Home and Alternate Site Infusion Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Home and Alternate Site Infusion Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Home and Alternate Site Infusion Therapy market.

Global Home and Alternate Site Infusion Therapy Scope and Market Size
Home and Alternate Site Infusion Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Home and Alternate Site Infusion Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Chemotherapy
Anti-infective Therapies
Immune Therapy
General Nursing Services
Others

Segment by Application
Residential
Ambulatory Infusion Centers
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Option Care Health
Coram CVS
UnitedHealth Group
HCA Healthcare
McLaren
CHI Health
Accredo Health
PharMerica
Cleveland Clinic